CIENCIASMEDICASNEWS: Medical News | Medical Articles: Automating enzyme immunoassay and ELISA research

jueves, 25 de julio de 2019

Medical News | Medical Articles: Automating enzyme immunoassay and ELISA research

	July 24, 2019
	Immunology
	The latest immunology news from News Medical

Automating enzyme immunoassay and ELISA research

Automating immunoassays has had a dramatic impact on immunology research for a whole range of clinical conditions from autoimmune diseases to oncology research. Leveraging full automation for ELISA, EIA, IFA and BLOT methods along with liquid handling protocols provides researchers with a high throughput method to provide fast and consistent results for their research.

Find Out More

Simplifying Gene Expression Analysis in Neuroscience Research

In this interview, Kevin Gamber describes two new technologies that are revolutionizing gene expression analysis for neuroscientists, one of which provides an in-depth look into neuroinflammation in the CNS

Immune system could be blamed for ineffectiveness of high-dose radiation against lung cancer

When it comes to using radiation against lung cancer, preliminary clinical studies were pretty clear: More is better. So why did a large phase 3 clinical trial find exactly the opposite - that stage III non-small cell lung cancer patients treated with higher doses of radiation actually had shorter overall survival than patients treated with lower-dose radiation?

	(edit here)

	Patients with biliary tract cancer have altered genetic architecture in immune system Patients with biliary tract cancer have altered genetic architecture in some immune system receptors. This has been shown by researchers at Karolinska Institutet in Sweden in a new study published in the journal Gastroenterology. It is hoped that the discovery will lead to new effective immunotherapy for these difficult to treat tumor types.

	New findings may help kick-start aging immune system The thymus is the powerhouse producing the immune system's T cells, which combat infection in our body. Yet this vital organ is one of the first to diminish in function as we age, resulting in a gradual loss of T cell production and eventually increased susceptibility to infections and cancer in the elderly.

	Findings suggest new ways to help the immune system fight pancreatic cancer Findings published today in the journal Science Translational Medicine suggest that a type of white blood cell called tumor associated macrophages that have been deceived by pancreatic cancer cells into not attacking them can be "re-programmed" by a specially designed molecule that activates a protein found on their surfaces.

	Cancer killing capability of lesser-known immune cells identified Researchers at Trinity College Dublin have identified, for the first time in esophageal cancer, the cancer killing capability of a lesser-known type of immune cell, presenting a new potential therapeutic target.

	Study shows how the mosquito immune system combats malaria parasites A new study from Iowa State University entomologists describes how mosquitoes fight off parasites that cause malaria, a disease that sickens millions of people every year. The study, published recently in the scientific journal Proceedings of the National Academy of Sciences, shows how the mosquito immune system combats malaria parasites at multiple stages of development.

	New study reveals 'clutch' proteins responsible for putting T cell activation 'into gear' In collaborative research, scientists from three continents were able to discover a crucial bit of information about how T cells move proteins inside them to drive the immune response. This could help evolve specific new treatments centered on T cell selectivity.

	Single-cell encapsulation technology can protect transplanted MSCs from immune attack Bone marrow transplants of hematopoietic stem cells have become standard treatment for a host of conditions including cancers of the blood and lymphatic systems, sickle cell anemia, inherited metabolic disorders, and radiation damage.

	Study reveals how aggressive prostate cancer metastasizes by evading the immune system Researchers at The University of Texas MD Anderson Cancer Center have discovered how an aggressive form of prostate cancer called double-negative prostate cancer (DNPC) metastasizes by evading the the immune system.